Invest in Biotech
Biotech is a continually expanding and highly innovative industry that utilises living organisms in search of cures for a myriad of illnesses, from Hepatitis C to cancer. It is also an industry in which businesses require a lot of funds in the early stage to get off the ground, for research and development as well as marketing and distribution.
Why Invest in Biotech?
Many attribute the increased demand for new innovations in the Biotech industry with an increase in life expectancy across the world and a greater number of people in emerging markets able to afford better medical care. Biotechnology experienced record amounts of investment in 2014 and was among the top performing industries in terms of investment raised. Growth has been rapid and the number of available Biotech investment opportunities has also increased alongside the industry growth.
Why Invest with SyndicateRoom?
SyndicateRoom provides the platform for you to invest in Biotech companies in the growth stage. The SyndicateRoom platform has been responsible for nearly 40% of all life science raises through equity crowdfunding since 2013 and therefore has had extensive experience in raising equity for companies in the Biotech field. Additionally, Biotech companies represent over 13% of funds raised on our platform. In addition to early-stage investment opportunities, SyndicateRoom investors can also invest in IPOs on the platform. In early 2017, SyndicateRoom was appointed as an official intermediary on the Arix Bioscience IPO. The biotech investment firm floated on the London Stock Exchange.
What SyndicateRoom offers:
1 | SyndicateRoom is the only equity crowdfunding platform that allows you to invest on the same economic terms as the lead investor. The lead investor sets the valuation of the company and conducts due diligence prior to the company going live on the platform
2 | Investors receive the same class of shares no matter how much they invest
3 | Equity crowdfunding offers you the opportunity to create a diversified investment portfolio
4 | Investors that qualify can benefit from tax relief through the EIS and SEIS schemes
Biotech investment portfolio
SyndicateRoom is FREE to join
With SyndicateRoom you gain access to invest alongside professional investors receiving the same share class and same share price.